Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae158 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Morgan Sooy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Diabetes Mellitus, Type 1, Hyperglycemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Colorado Diabetes Research Center, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Context
In Colorado children, the prevalence of diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes has been increasing over time.
Objective
To evaluate the prevalence of and factors involved in DKA at type 1 diabetes diagnosis among participants followed in monitoring research studies before diagnosis compared to patients from the community.
Methods
We studied patients < 18 years diagnosed with type 1 diabetes between 2005 and 2021 at the Barbara Davis Center for Diabetes and compared the prevalence of and factors associated with DKA at diagnosis among participants in preclinical monitoring studies vs those diagnosed in the community.
Results
Of 5049 subjects, 164 were active study participants, 42 inactive study participants, and 4843 were community patients. Active study participants, compared to community patients, had lower HbA1c (7.3% vs 11.9%; P < .001) and less frequently experienced DKA (4.9% vs 48.5%; P < .001), including severe DKA (1.2% vs 16.2%; P < .001). Inactive study participants had intermediate levels for both prevalence and severity of DKA. DKA prevalence increased in community patients, from 44.0% to 55%, with less evidence for a temporal trend in study participants. DKA prevalence was highest in children < 2 years (13% in active study participants vs 83% in community patients). In community patients, younger age (P = .0038), public insurance (P < .0001), rural residence (P < .0076), higher HbA1c (P < .0001), and ethnicity minority status (P < .0001) were associated with DKA at diagnosis.
Conclusion
While DKA prevalence increases in community patients over time, it stayed < 5% in active research participants, who have a 10 times lower prevalence of DKA at diagnosis, including among minorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO 80045, USA.
- Department of Pediatrics, Section of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
ORCID-Profile: Morgan Sooy, Laura Pyle, Andrea K Steck
Förderung
- Colorado Diabetes Research Center
- NIDDK NIH HHS
- NCATS NIH HHS
- NIH
- NCATS
Zitieren
APA
Sooy, M., Pyle, L., Alonso, G. T., Broncucia, H. C., Rewers, A., Gottlieb, P. A., Simmons, K. M., Rewers, M. J., & Steck, A. K. (2024). Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae158
Vancouver
Sooy M, Pyle L, Alonso GT, Broncucia HC, Rewers A, Gottlieb PA, et al. Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae158
BibTeX
@article{Sooy2024,
author = {Sooy, Morgan and Pyle, Laura and Alonso, Guy Todd and Broncucia, Hali C and Rewers, Arleta and Gottlieb, Peter A and Simmons, Kimber M and Rewers, Marian J and Steck, Andrea K},
title = {Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae158}
}
EUVIMED